HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhong-Zhen Guan Selected Research

VAP-cyclo protocol

12/2007[Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
12/2005[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
12/2004[Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
11/2004[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
4/2003[Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhong-Zhen Guan Research Topics

Disease

21Neoplasms (Cancer)
06/2018 - 03/2003
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014 - 05/2004
9Lymphoma (Lymphomas)
10/2008 - 04/2004
9Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2007 - 04/2003
7Nasopharyngeal Carcinoma
10/2010 - 12/2003
5Colorectal Neoplasms (Colorectal Cancer)
01/2013 - 08/2003
5B-Cell Lymphoma (Lymphoma, B Cell)
06/2008 - 12/2005
4Lung Neoplasms (Lung Cancer)
06/2018 - 02/2013
3Alopecia (Baldness)
02/2013 - 08/2006
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2012 - 12/2005
3Breast Neoplasms (Breast Cancer)
12/2008 - 12/2004
3Hepatitis
06/2008 - 03/2006
3Disease Progression
12/2006 - 08/2003
2Vomiting
02/2013 - 08/2005
2Neutropenia
02/2013 - 10/2011
2Carcinoma (Carcinomatosis)
02/2013 - 12/2006
2Nausea
02/2013 - 08/2005
2Neoplasm Metastasis (Metastasis)
01/2013 - 12/2007
2Diarrhea
10/2011 - 08/2005
2Burkitt Lymphoma (Burkitt's Lymphoma)
08/2009 - 12/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
05/2009 - 12/2005
2Fever (Fevers)
12/2008 - 04/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2008 - 08/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2007 - 12/2003
2Leukemia
10/2006 - 04/2004
2Pruritus (Itching)
04/2006 - 08/2005
2Exanthema (Rash)
04/2006 - 08/2005
2Infections
12/2005 - 08/2005
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2004 - 08/2004
1Pleural Effusion (Pleural Effusions)
08/2014
1Anorexia
02/2013
1Thrombocytopenia (Thrombopenia)
02/2013
1Anemia
02/2013
1Fatigue
02/2013
1Hypertension (High Blood Pressure)
01/2013
1Liver Diseases (Liver Disease)
01/2013
1Proteinuria
01/2013
1Hemorrhage
01/2013
1Heart Failure
12/2008
1Cardiotoxicity
12/2008
1Hepatitis B
06/2008
1Triple Negative Breast Neoplasms
06/2008

Drug/Important Bio-Agent (IBA)

8Rituximab (Mabthera)FDA Link
06/2012 - 12/2004
6Cisplatin (Platino)FDA LinkGeneric
02/2013 - 05/2004
6Doxorubicin (Adriamycin)FDA LinkGeneric
06/2012 - 04/2003
5ErbB Receptors (EGF Receptor)IBA
12/2006 - 05/2004
5Gefitinib (Iressa)FDA Link
12/2006 - 05/2004
4Proteins (Proteins, Gene)FDA Link
04/2013 - 09/2004
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2013 - 08/2003
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2012 - 04/2003
4Prednisone (Sone)FDA LinkGeneric
06/2012 - 04/2003
4Vincristine (Oncovin)FDA LinkGeneric
06/2012 - 04/2003
4Fluorouracil (Carac)FDA LinkGeneric
10/2011 - 12/2004
3Paclitaxel (Taxol)FDA LinkGeneric
08/2014 - 11/2004
3Trastuzumab (Herceptin)FDA Link
04/2013 - 12/2004
3Bevacizumab (Avastin)FDA Link
01/2013 - 12/2010
3Docetaxel (Taxotere)FDA Link
04/2008 - 08/2006
3PlatinumIBA
01/2008 - 08/2005
3GemcitabineFDA Link
01/2008 - 11/2004
3AntigensIBA
11/2007 - 12/2005
3Pharmaceutical PreparationsIBA
12/2006 - 08/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2006 - 08/2005
3Biological ProductsIBA
09/2006 - 08/2004
2Carboplatin (JM8)FDA LinkGeneric
08/2014 - 02/2013
2EnzymesIBA
02/2013 - 04/2007
2Irinotecan (Camptosar)FDA LinkGeneric
01/2013 - 10/2011
2Leucovorin (Folinic Acid)FDA Link
10/2011 - 01/2008
2Estrogen ReceptorsIBA
06/2008 - 12/2004
2Progesterone Receptors (Progesterone Receptor)IBA
06/2008 - 12/2004
2Lamivudine (Epivir)FDA Link
06/2008 - 03/2006
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
11/2007 - 12/2005
2Transaminases (Aminotransferases)IBA
12/2006 - 08/2006
2Lymphotoxin-alpha (Lymphotoxin)IBA
12/2006 - 08/2003
2IodidesIBA
10/2006 - 02/2004
2DNA Primase (Primase)IBA
10/2006 - 02/2004
2anilinoquinazolineIBA
11/2004 - 05/2004
2Tyrosine Kinase InhibitorsIBA
11/2004 - 05/2004
1diammine(1,1- cyclobutanedicarboxylate)platinum(II)IBA
08/2014
1AntiemeticsIBA
02/2013
1Cytotoxins (Cytolysins)IBA
12/2010
1XELOXIBA
12/2010
1Cetuximab (Erbitux)FDA Link
12/2010
1Etoposide (VP 16)FDA LinkGeneric
05/2009
1Methotrexate (Mexate)FDA LinkGeneric
05/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2009
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2009
1Vindesine (Vindesin)IBA
05/2009
1IfosfamideFDA LinkGeneric
05/2009

Therapy/Procedure

26Drug Therapy (Chemotherapy)
04/2013 - 04/2003
9Therapeutics
06/2018 - 03/2003
5VAP-cyclo protocol
12/2007 - 04/2003
3Intravenous Infusions
10/2011 - 04/2003
2Chemoradiotherapy
10/2010 - 12/2005
2Adjuvant Chemotherapy
12/2008 - 12/2007
2Aftercare (After-Treatment)
12/2008 - 11/2004
1Immunotherapy
06/2018
1Precision Medicine
01/2017
1Biological Therapy
12/2010
1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2010
1Oral Administration
06/2008